ArticleCancers2023

Astragaloside IV Attenuates Programmed Death-Ligand 1-Mediated Immunosuppression during Liver Cancer Development via the miR-135b-5p/CNDP1 Axis.

Yang Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.